Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in J Immunol Retrieve available abstracts of 7 articles: HTML format

Single Articles

February 2023
1. SUBRAMANIAN K, Paul S, Libby A, Patterson J, et al
   HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction.
   J Immunol. 2023 Feb 1:ji2100186. doi: 10.4049/jimmunol.2100186.
   PubMed     Abstract available
   
   
   June 2022
2. LIU Y, Qin L, Wang J, Xie X, et al
   miR-146a Maintains Immune Tolerance of Kupffer Cells and Facilitates Hepatitis B Virus Persistence in Mice.
   J Immunol. 2022;208:2558-2572.
   PubMed     Abstract available
   
   
   January 2022
3. WANG X, Liang Y, Wang H, Zhang B, et al
   The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis.
   J Immunol. 2022 Jan 19. pii: jimmunol.2100481. doi: 10.4049/jimmunol.2100481.
   PubMed     Abstract available
   
   
   
4. LI W, Duan X, Zhu C, Liu X, et al
   Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-beta1-Induced OCT4/Nanog Pathway.
   J Immunol. 2022 Jan 12. pii: jimmunol.2001453. doi: 10.4049/jimmunol.2001453.
   PubMed     Abstract available
   
   
   August 2021
5. MAZOUZ S, Boisvert M, Abdel-Hakeem MS, Khedr O, et al
   Expansion of Unique Hepatitis C Virus-Specific Public CD8(+) T Cell Clonotypes during Acute Infection and Reinfection.
   J Immunol. 2021 Aug 2. pii: jimmunol.2001386. doi: 10.4049/jimmunol.2001386.
   PubMed     Abstract available
   
   
   April 2021
6. BARRIOCANAL M, Prior C, Suarez B, Unfried JP, et al
   Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth.
   J Immunol. 2021;206:1932-1942.
   PubMed     Abstract available
   
   
   January 2021
7. RODRIGUEZ-GARCIA E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, et al
   AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-alpha Production.
   J Immunol. 2021;206:376-385.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: